3 September 2021 Current Affairs
Biological E vaccine has received DGCI approval to conduct phase 2/3 trials on children. What is the name of its COVID vaccine candidate?
Hyderabad-based Biological E Limited got approval from the Drug Controller General of India (DCGI) to conduct Phase 2 & 3 clinical trials for its COVID-19 vaccine Corbevax on children aged between 5 and 18 years of age with certain conditions.
South Korean lawmakers passed the world's first law to force tech giants such as Google and Apple to offer alternative payment systems on their app stores.
EXAMIANS